Search Results 671-680 of 8497 for 78%

  1. Study of RP-6306 With FOLFIRI in Advanced Solid Tumors - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

    About this study. The purpose of this multicenter, double-blind, randomized, placebo-controlled study is to evaluate the safety and efficacy of emricasan in ...

  3. A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer - Mayo Clinic

    About this study. The purpose of these phase I/II trial studies is to analyze the side effects and best dose of liposomal irinotecan and rucaparib when ...

  5. https://www.mayoclinic.org/arabic_procedure_concepts.xml

  6. A Study to Assess The Amyotrophic Lateral Sclerosis (ALS) Patient Experience - Mayo Clinic

    The purpose of this study is to support and extend the results of the FORTITUDE-ALS clinical trial, a clinical trial of an investigational drug (reldesemtiv) ...

  7. A Study to Evaluate S-600918 in Adults With Refractory Chronic Cough - Mayo Clinic

    The primary objective of this study is to determine the optimal dose of S-600918 in patients with refractory chronic cough by evaluating the change from ...

  8. A Study of the Impact of Frailty on Health Outcomes following Aortic Valve Replacement - Mayo Clinic

    The purpose of this study is to determine what factors predict poor surgical outcomes, and the extent to which patient-centered outcomes differ between ...

  9. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

  10. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    The purpose of this study is to determine the side effects of treatment with Nivolumab by itself or in combination in patients with relapsed/refractory ...